Patent
Process for making HIV protease inhibitors
Merck & Co., Inc.
US 5,637,711GrantedGranted Jun 10, 1997Filed Jun 7, 1995
Intermediates of structural formula ##STR1## can be made by reacting a primary or secondary amine with glycosidol or an activated derivative thereof. The process and intermediates are useful for synthesizing HIV protease inhibitor compounds.
Claims
1
1 independent claim
Filing to grant
2.0 years
Pendency
1ClaimsFirst of 1
- 1
A compound of formula ##STR46##
2Description
Introduction
This application is a divisional application of Merck Case 19045DA, U.S. Ser. No. 08/341,334, filed Dec. 16, 1994, abandoned, which is a continuation of Merck Case 19045, U.S. Ser. No. 08/092,627, filed Jul. 16, 1993, abandoned.